HomeESPR • NASDAQ
add
Esperion Therapeutics Inc
$0.92
Makalipas ang Oras ng Trabaho:(0.55%)+0.0051
$0.93
Sarado: Abr 25, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$0.88
Sakop ng araw
$0.85 - $0.94
Sakop ng taon
$0.82 - $3.94
Market cap
182.57M USD
Average na Volume
5.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 69.11M | 114.30% |
Gastos sa pagpapatakbo | 36.92M | -18.71% |
Net na kita | -21.32M | 62.16% |
Net profit margin | -30.85 | 82.34% |
Kita sa bawat share | -0.10 | 79.74% |
EBITDA | -4.39M | 89.63% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 144.76M | 76.01% |
Kabuuang asset | 343.82M | 67.07% |
Kabuuang sagutin | 732.54M | 10.86% |
Kabuuang equity | -388.72M | — |
Natitirang share | 197.85M | — |
Presyo para makapag-book | -0.45 | — |
Return on assets | -3.36% | — |
Return on capital | -5.64% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -21.32M | 62.16% |
Cash mula sa mga operasyon | -34.95M | 5.68% |
Cash mula sa pag-invest | 0.00 | — |
Cash mula sa financing | 35.00M | 682.73% |
Net change in cash | 44.00K | 100.14% |
Malayang cash flow | -24.72M | 13.40% |
Tungkol
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Itinatag
May 1998
Website
Mga Empleyado
304
